Targeted next-generation sequencing panel to investigate antiplatelet adverse reactions in acute coronary syndrome patients undergoing percutaneous coronary intervention with stenting
Authors:
Open Access
- 6 June 2024
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 240, 109060
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- A novel therapeutic strategy for atherosclerosis: autophagy-dependent cholesterol effluxJournal of Physiology and Biochemistry, 2022
- Utility of a pharmacogenetic-driven algorithm in guiding dual antiplatelet therapy for patients undergoing coronary drug-eluting stent implantation in ChinaEuropean Journal of Clinical Pharmacology, 2021
- Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary InterventionJAMA, 2020
- Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics ConsortiumClinical Pharmacology & Therapeutics, 2020
- Genomewide Association Study Identifies Novel Genetic Loci That Modify Antiplatelet Effects and Pharmacokinetics of ClopidogrelClinical Pharmacology & Therapeutics, 2016
- Bile acid excess induces cardiomyopathy and metabolic dysfunctions in the heartHepatology, 2016
- Targeted Next‐Generation Sequencing for Comprehensive Genetic Profiling of PharmacogenesClinical Pharmacology & Therapeutics, 2016
- Polymorphisms of pesticide-metabolizing genes in children living in intensive farming communitiesChemosphere, 2015
- Impact of New Genomic Technologies on Understanding Adverse Drug ReactionsClinical Pharmacokinetics, 2015
- Clinical Association Between Pharmacogenomics and Adverse Drug ReactionsDrugs, 2015